Vimarsana
Biggest News Aggregation in the World

David Fellows News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Fellows. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Fellows Today - Breaking & Trending Today

Kenneth S. Fellows | The Westfield News |February 19, 2024 - Vimarsana News

Kenneth S. Fellows | The Westfield News |February 19, 2024

WESTFIELD - Kenneth S. Fellows of Westfield, Massachusetts passed away at his home surrounded by his family in the early hours of Friday, February 16th,

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer - Vimarsana News

Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer

Proven Industry Executive Brings More Than 25 Years of Leadership ExperienceFOSTER CITY, Calif., Feb. 07, 2024 -- Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company...

Join Boulder JCC's Men of the J as They Celebrate One Year! – Boulder Jewish News - Vimarsana News

Join Boulder JCC's Men of the J as They Celebrate One Year! – Boulder Jewish News

Join the Men of the J in celebration to mark the one-year anniversary at the Boulder JCC on Thursday, January 25 for dinner and a beer tasting from local company Wibby Brewing. 

Boulder JCC's Men of the J Celebrate One Year! – Boulder Jewish News - Vimarsana News

Boulder JCC's Men of the J Celebrate One Year! – Boulder Jewish News

Join the Men of the J in celebration to mark the one-year anniversary at the Boulder JCC on Thursday, January 25 for dinner and a beer tasting from local company Wibby Brewing. 

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer - Vimarsana News

Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer

FOSTER CITY, Calif., Nov. 27, 2023 -- Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious...